BIRMINGHAM, Ala., Feb. 26, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held March 10-12, 2026. Encompass Health's President and Chief Executive Officer Mark Tarr and Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat on Wednesday, March 11, 2026, from 9-9:25 a.m. ET. From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a re ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 ________________________________________________________ Encompass Health Corporation (Exact Name of Registrant as Specified in its ...

Encompass Health recognized for corporate excellence on Fortune and Forbes 2026 lists [Accessibility Statement] Skip NavigationBIRMINGHAM, Ala., Feb. 24, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, today announced it has been named to the [Fortune 2026 World's Most Admired Companies] list and the [Forbes 2026 America's Best Companies] list. These distinctions underscore the Company's continued excellence in patient c ...

New York, New York--(Newsfile Corp. - February 24, 2026) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear micro modular reactor (MMR) and technology company focused on developing clean energy solutions, today announced that it has signed a Memorandum of Understanding (MOU) with EHC Investment L.L.C (EHC), a diversified United Arab Emirates (UAE) investment holding company based in Abu Dhabi, to explore a joint venture aimed at deploying micro modular re ...

Company Overview - Encompass Health Corp. (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a national footprint of 173 hospitals across 39 states and Puerto Rico [1] - The company is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and is ranked among Fortune's World's Most Admired Companies and Forbes' America's Best Companies [1] New Hospital Announcement - Encompass Health announced plans to build a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, aimed at serving patients recovering from debilitating illnesses and injuries [1] - The hospital will provide 24-hour nursing care and specialized therapies, including physical, occupational, and speech therapies, to help patients restore function and improve quality of life [1] - The facility will feature private patient rooms, a therapy gym with advanced rehabilitation technologies, an activities of daily living suite, an in-house dialysis suite, and additional amenities [1] Strategic Expansion - The new hospital is expected to open in 2027 and will be Encompass Health's second location in Mississippi, complementing an existing facility in Gulfport [1] - The expansion aims to bring high-quality, specialized rehabilitation services closer to residents in the Jackson area and central Mississippi [1]

Core Insights - Enhabit, Inc. and Encompass Health Corporation have successfully collected $43.1 million in full satisfaction of their claims for attorneys' fees and mitigation damages [1] Legal Proceedings - The claims were filed in the Delaware Court of Chancery against former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey [1] - These claims are related to a December 2024 judgment that favored Enhabit and Encompass [1]

Core Insights - Encompass Health Corporation is a leading provider of inpatient rehabilitation services in the U.S., recognized for its clinical quality and capital management, with a focus on sustainable double-digit EBITDA growth driven by demographic trends and regulatory barriers [1] Financial Performance - In Q4 2025, Encompass Health reported an adjusted EPS of $1.46, reflecting a 24.8% increase year-over-year and exceeding the Zacks Consensus Estimate by 13.2% [3] - The company's net operating revenues reached $1.5 billion, representing a 9.9% year-over-year growth, attributed to higher net revenue per discharge and an increase in discharges [3] Financial Metrics - Encompass Health has a P/E ratio of 19.29, indicating that investors are willing to pay $19.29 for every dollar of earnings [4] - The price-to-sales ratio stands at 1.85, and the enterprise value to sales ratio is 1.88, reflecting the market's valuation of the company [4] - The company maintains a low debt-to-equity ratio of 0.08, showcasing a conservative leverage approach that enhances financial resilience [4] Operational Strength - The company owns 79% of its real estate, which supports its operational leverage and efficient hospital development [5] - Encompass Health's current ratio is 1.08, indicating its capability to meet short-term liabilities [5] - The company is recognized as a strong growth stock, with Zacks Style Scores assisting investors in identifying stocks with high short-term market outperformance potential [5]

Core Insights - Encompass Health (EHC) is positioned as a sustainable growth story within the healthcare services sector, contrasting with other segments that are influenced by speculative disruption and unpredictable reimbursement dynamics [1] Company Overview - Encompass Health is the largest provider in its field, indicating a strong market presence and potential for continued growth [1]

Core Insights - Encompass Health Corporation (EHC) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.46, exceeding the Zacks Consensus Estimate by 13.2% and reflecting a year-over-year increase of 24.8% [1][9] - The company's net operating revenues reached $1.5 billion, marking a 9.9% year-over-year improvement and slightly surpassing the consensus estimate by 0.2% [1][9] Financial Performance - The growth in revenue was driven by higher net revenue per discharge, which rose 4.1% year over year, and an increase in total discharges, which grew 5.3% year over year to 67,238, although this figure marginally missed the consensus estimate by 0.3% [2][5] - Total operating expenses increased by 7.5% year over year to $1.26 billion, primarily due to rising salaries and benefits, but this was slightly below the estimated $1.28 billion [6][9] - Net income for the quarter climbed 23.7% year over year to $203.1 million, while adjusted EBITDA grew 15.9% year over year to $335.6 million, surpassing the estimate of $304 million [6][9] Operational Developments - In the fourth quarter, Encompass Health added 37 beds to its existing hospitals and opened three de novo hospitals [7][9] - For the full year 2025, the company reported operating revenues of $5.94 billion, up from $5.37 billion in 2024, with adjusted net income per share increasing to $5.45 from $4.43 [13] Future Outlook - For 2026, net operating revenues are projected to be between $6.365 billion and $6.465 billion, indicating growth from the 2025 figure [14] - Adjusted EBITDA is expected to range from $1.34 billion to $1.38 billion, reflecting an increase from the 2025 figure [14] - The company anticipates adjusted EPS from continuing operations to be between $5.81 and $6.10, up from $5.45 in 2025 [15] - Encompass Health plans to open eight de novo hospitals and add approximately 175 beds to existing facilities in 2026 [16] Growth Strategy - Management aims to inaugurate six to ten de novo hospitals each year from 2023 to 2027, with a target of adding 80-120 beds annually and achieving a compound annual growth rate (CAGR) of 6-8% in discharges during the same period [17]

Financial Performance - In Q4, revenue increased by 9.9% to $1.5 billion, and adjusted EBITDA rose by 15.9% to $335.6 million, driven by 5.3% discharge growth and a 4.1% increase in net revenue per discharge [1][5] - For the full year 2025, revenue grew by 10.5%, with EBITDA increasing by 14.9%, supported by operating leverage and disciplined expense management [3][5] - Adjusted free cash flow for the full year was $818 million, reflecting an 18.5% increase [9] Labor and Operational Efficiency - Premium labor costs decreased significantly, down more than $21 million year-over-year in 2025, with Q4 premium labor at $23.8 million, the lowest since Q1 2021 [2][5][7] - The company added approximately 300 same-store registered nurses (RNs) during 2025, contributing to improved operational efficiency [7] Capacity Expansion and Growth Strategy - Management plans to add 517 beds in 2025 through new hospitals and expansions, with ongoing investments expected to meet a growing target demographic [12] - A new 24-bed small-format hospital prototype is set to launch in 2027 as part of a hub-and-spoke strategy [13] 2026 Guidance - For 2026, management guided net revenue of $6.365–6.465 billion, adjusted EBITDA of $1.34–1.38 billion, and adjusted EPS of $5.81–6.10, with a leverage target of approximately 1.83x [4][18] Regulatory and Payer Dynamics - The company reported a 93% affirmation rate for its Alabama hospitals under the RCD model, indicating effective engagement with CMS [16] - Management expressed concerns about challenges with a national Medicare Advantage payer, which affected conversion rates despite referral growth [20]